Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$1.22B |
| 3 |
NVIDIA
NVDA
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$1.01B |
| 5 |
Procter & Gamble
PG
|
+$784M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$619M |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$582M |
| 3 |
Phillips 66
PSX
|
+$575M |
| 4 |
Eli Lilly
LLY
|
+$377M |
| 5 |
HES
Hess
HES
|
+$326M |
Sector Composition
| 1 | Technology | 31.4% |
| 2 | Financials | 12.71% |
| 3 | Consumer Discretionary | 10.47% |
| 4 | Healthcare | 9.99% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Verrica Pharmaceuticals
VRCA
$47.2M
| $86K | ﹤0.01% |
1,459
-1,405
| -49% | -$82.8K |
|
3552
Aclaris Therapeutics
ACRS
$231M
| $85K | ﹤0.01% |
68,266
-107,653
| -61% | -$134K |
|
3553
CompoSecure
CMPO
$1.94B
| $85K | ﹤0.01% |
14,100
-13,195
| -48% | -$79.5K |
|
3554
Citius Pharmaceuticals
CTXR
$20.6M
| $85K | ﹤0.01% |
3,779
-2,974
| -44% | -$66.9K |
|
3555
Marine Products Corp
MPX
$317M
| $85K | ﹤0.01% |
7,250
-7,801
| -52% | -$91.5K |
|
3556
Unilever
UL
$155B
| $85K | ﹤0.01% |
1,702
+1,066
| +168% | +$53.2K |
|
|
IVAC
3557
DELISTED
Intevac Inc
IVAC
| $85K | ﹤0.01% |
22,316
-17,206
| -44% | -$65.5K |
|
|
AKYA
3558
DELISTED
Akoya BioSciences
AKYA
| $84K | ﹤0.01% |
17,928
-15,465
| -46% | -$72.5K |
|
3559
Nuvectis Pharma
NVCT
$161M
| $84K | ﹤0.01% |
10,293
+39
| +0.4% | +$318 |
|
3560
Invesco NASDAQ 100 ETF
QQQM
$59.9B
| $84K | ﹤0.01% |
460
| – | – |
|
3561
Bluerock Homes Trust
BHM
$52.8M
| $83K | ﹤0.01% |
4,900
| – | – |
|
3562
Cadiz
CDZI
$285M
| $83K | ﹤0.01% |
28,552
-27,510
| -49% | -$80K |
|
3563
iShares MSCI Indonesia ETF
EIDO
$317M
| $83K | ﹤0.01% |
3,700
| – | – |
|
3564
Paysign
PAYS
$295M
| $83K | ﹤0.01% |
22,739
-22,969
| -50% | -$83.8K |
|
|
TPIC
3565
DELISTED
TPI Composites
TPIC
| $83K | ﹤0.01% |
28,770
-27,968
| -49% | -$80.7K |
|
3566
Perspective Therapeutics
CATX
$250M
| $82K | ﹤0.01% |
+6,901
| New | +$82K |
|
3567
First United
FUNC
$237M
| $82K | ﹤0.01% |
3,579
| – | – |
|
3568
Red Robin
RRGB
$110M
| $82K | ﹤0.01% |
10,703
-11,301
| -51% | -$86.6K |
|
3569
Sportsman's Warehouse
SPWH
$115M
| $82K | ﹤0.01% |
26,344
-25,144
| -49% | -$78.3K |
|
|
ZPTAW
3570
DELISTED
Zapata Computing Holdings Inc. Warrant
ZPTAW
| $82K | ﹤0.01% |
200,000
| – | – |
|
3571
New Oriental
EDU
$8.51B
| $80K | ﹤0.01% |
922
-210,265
| -100% | -$18.2M |
|
3572
Sight Sciences
SGHT
$187M
| $80K | ﹤0.01% |
15,239
-14,486
| -49% | -$76K |
|
3573
Motley Fool 100 Index ETF
TMFC
$1.67B
| $80K | ﹤0.01% |
1,606
| – | – |
|
|
ADAP
3574
Adaptimmune Therapeutics
ADAP
$13M
| $79K | ﹤0.01% |
50,061
| – | – |
|
3575
Mercer International
MERC
$214M
| $79K | ﹤0.01% |
7,977
+39
| +0.5% | +$386 |
|